基于NR2B基因探讨疏肝与补肾法对吗啡精神依赖的调节作用及机制

目的：探讨补肾法与舒肝法对大鼠吗啡精神依赖的调节作用及机制。方法：使用盐酸吗啡建立大鼠精神依赖模型（conditioned place preference,CPP）,采用Obersiver5．0行为学软件分析大鼠的CPP效应,并利用RealtimePCR方法测定伏核和前额叶皮质内NR2B亚基的mRNA含量。结果：与对照组相比,模型组大鼠在白侧累积停留时间极显著长于对照组（P〈0．01）,同时伏核与前额叶皮质中NR2B的mRNA水平也显著升高（P〈0．01和P〈0．05）;与模型组相比,补肾组和舒肝组大鼠在白侧的累积停留时间显著下调（P〈0．05）,疏肝组NR2B的mRNA也显著下降（P〈0．05）,而补肾组变化不显著。结论：①补肾法与舒肝法对吗啡引起的精神依赖均有调节作用。②舒肝法的作用机制可能在于通过影响伏核和前额叶皮质中NR2B亚基的mRNA表达进一步调节精神依赖的相关神经通路。③补肾法的作用机制与NR2B亚基的mRNA表达关系不密切,其调节的具体机制尚有待研究。     

白藜芦醇甙对慢性酒精中毒大鼠学习记忆及前额叶皮质NR2B受体表达的影响

目的：研究白藜芦醇甙对慢性酒精中毒大鼠学习记忆及大脑前额叶皮质N-甲基-D-天冬氨酸受体2B亚基（NR2B）表达的影响。方法：建立大鼠慢性酒精中毒模型,Y-型迷宫测试空间学习与记忆成绩,免疫组织化学方法检测前额叶皮质NR2B表达,聚合酶链式反应（PCR）分析前额叶皮质NR2B mRNA的改变。结果：学习记忆测试显示模型组大鼠学习记忆成绩比正常组明显下降（P〈0.01）,各剂量组与模型组相比,学习记忆成绩明显上升（P〈0.05或P〈0.01）;免疫组化结果表明模型组大鼠前额叶皮质区NR2B阳性表达较正常组明显增多,各剂量组与模型组相比,NR2B mRNA阳性表达明显减少;PCR结果表明模型组大鼠前额叶皮质区NR2B mRNA表达较正常组明显上升（P〈0.01）,各剂量组与模型组相比,NR2B mRNA表达明显下降,差异有显著性（P〈0.01）。结论：白藜芦醇甙可能通过对NMDA受体4F53亚基NR2B蛋白表达的调节而发挥抗酒精中毒作用。     

多巴胺D2受体拮抗剂、激动剂对SD大鼠条件化位置偏好的影响

通过慢性吗啡处理方式建立起SD大鼠吗啡依赖的条件化位置偏好(CPP)模型,用行为学手段研究多巴胺(DA)D2受体拮抗剂及激动剂对SD大鼠CPP的影响,探讨眶额叶DAD2受体在阿片精神依赖中的作用。通过腹腔注射吗啡同环境因素相结合,建立大鼠吗啡依赖的CPP模型;采用局部脑内微量注射法向额叶注射DAD2受体拮抗剂或激动剂或盐水(对照组),以得到SD大鼠在戒断期间的CPP的时间数据。CPP显示DAD2受体拮抗剂组与对照组相比,从戒断第2天起,前者表现出更明显的CPP增加现象,差异显著(P<0·05)。而DAD2受体激动剂组与对照组相比无显著差异(P>0·05)。采用腹腔小剂量注射吗啡,成功地建立了吗啡依赖SD大鼠的CPP模型;眶额叶微量注射DAD2受体拮抗剂增加了CPP时间,提示眶额叶多巴胺系统在吗啡依赖的过程中有着较为重要的作用;也提示了对于已经成瘾的动物,损伤其眶额叶,会使药物渴求增强。因而提示对于药物依赖患者进行手术干预治疗要极其慎重。     

M受体对吗啡戒断大鼠脊髓和脑干NMDA受体基因表达及中脑导水管周围灰质中谷氨酸释放的调节

应用鞘内注射反义寡脱氧核苷酸技术和RT—PCR反应,观察毒蕈碱型乙酰胆碱受体(muscarinic acetylcholine receptor,M)对吗啡依赖大鼠脊髓和脑干NMDA受体NR1A和NR2A mRNA表达和中脑导水管周围灰质区(periaqueductal grey,PAG)中谷氨酸释放的影响。结果显示,吗啡依赖大鼠脊髓NR1A和NR2A mRNA表达明显升高,而脑干中NR1A和NR2A mRNA表达没有显著变化;注射纳洛酮后1h,吗啡戒断大鼠脊髓和脑干中NR1A和NR2A表达显著高于依赖组,经NMDA受体拮抗剂MK801(0．125mg／kg,i．p．)、M受体拮抗剂东莨菪碱(0．5mg／kg,i．p．)、M1受体拮抗剂呱伦西平(10mg/kg,i．p．)和NOS抑制剂L-NAME(10mg／kg,i．p．)处理后,脊髓和脑干中NR1A和NR2A基因表达都较戒断组明显减少。在纳洛酮激发前24h鞘内注射NR1A和M2受体的反义寡脱氧核苷酸(4μg／只),戒断症状评分值及脊髓和脑干的NR1A mRNA的表达均较对照组明显减少。吗啡依赖大鼠在纳洛酮注射前24h鞘内注射M2受体反义寡脱氧核苷酸(4μg/只),可以明显减少PAG内透析液中谷氨酸含量。上述结果提示：NMDA受体的基因表达和谷氨酸释放参与吗啡戒断过程,而这种表达受到M受体的调节。     

NR2B与钩藤碱抑制甲基苯丙胺依赖斑马鱼CPP的关系研究

研究N-甲基-D-天冬氨酸受体2B亚基(NR2B)与钩藤碱抑制甲基苯丙胺依赖斑马鱼条件性位置偏爱(condition place preference,CPP)作用的关系。斑马鱼分为5组:空白组、模型组(甲基苯丙胺40 mg/kg)、钩藤碱低剂量组(40 mg/kg)、钩藤碱高剂量组(80 mg/kg)、氯胺酮组(150 mg/kg)。腹腔注射甲基苯丙胺后,进行斑马鱼条件性位置偏爱训练,建立斑马鱼甲基苯丙胺CPP依赖模型,分析各组斑马鱼在CPP箱中的活动,以及各组斑马鱼脑内NR2B的表达情况。腹腔注射甲基苯丙胺40 mg/kg后,甲基苯丙胺依赖斑马鱼CPP模型成功建立。与空白组相比,模型组斑马鱼在伴药箱中的时间明显增加;与模型组相比,钩藤碱高剂量组斑马鱼在伴药箱中的时间明显减少。与空白组相比,模型组斑马鱼脑内NR2B阳性细胞数明显增加;给予钩藤碱干预后,斑马鱼脑内NR2B阳性细胞数明显减少。与空白组比较,模型组斑马鱼脑内NR2B蛋白表达明显增强,而给予钩藤碱干预后,NR2B蛋白表达减弱。钩藤碱可抑制甲基苯丙胺诱导的斑马鱼CPP效应,其机制与抑制NR2B的表达有关。     

心脑佳配方对慢性酒精中毒大鼠学习记忆及海马NMDA受体亚基NR2B表达的影响

目的：研究心脑佳配方对慢性酒精中毒大鼠学习记忆及海马N-甲基-D-天冬氨酸（NMDA）受体2B亚基（NR2B）表达的影响。方法：建立大鼠慢性酒精中毒模型,分别检测学习与记忆成绩、超氧化物歧化酶（SOD）活性和海马区NR2B mRNA表达。结果：学习记忆测试显示模型组大鼠学习记忆成绩比正常组明显下降（P〈0.01）,各用药组与模型组相比,学习记忆成绩明显上升（P〈0.05或P〈0.01）;模型组大鼠脑组织中SOD活性较正常组显著降低（P〈0.01）,而各用药组与模型组相比,脑组织中SOD活性显著升高（P〈0.05或P〈0.01）;PCR结果表明模型组大鼠海马区NR2B mRNA表达较正常组明显上升（P〈0.01）,各用药组与模型组相比,NR2B mRNA表达明显下降,差异有显著性（P〈0.01）。结论：心脑佳配方可能通过对NMDA受体亚基NR2B蛋白表达的调节而发挥抗酒精中毒作用。     

西酞普兰对慢性应激大鼠额叶皮质神经细胞bax mRNA、bcl-2 mRNA表达及凋亡的影响

目的:探讨西酞普兰对慢性应激大鼠的额叶皮质神经细胞bax、bcl-2 mRNA表达的影响。方法:取24只雄性SD大鼠随机分为对照组(不进行任何处理)、应激组(应激+生理盐水灌胃)、实验组(应激+西酞普兰灌胃),采用强迫游泳制造慢性应激模型(15 min/d,共4周),用原位杂交技术检测bax、bcl-2 mRNA表达情况,TUNEL法检测细胞凋亡,尼康图像分析(NIS DR)软件测量各指标阳性细胞数量。结果:应激组较对照组,大鼠额叶皮质bax mRNA阳性表达细胞明显增多(P0.01)、染色加深;bcl-2 mRNA阳性表达细胞明显减少(P0.01)且染色变浅,且TUNEL阳性细胞数量增多(P0.01),染色增强。而实验组较应激组大鼠,额叶皮质bax mRNA阳性表达细胞减少(P0.01)、染色变浅,bcl-2 mRNA阳性表达细胞明显增多(P0.05),染色加深,且TUNEL阳性细胞数量减少(P0.01),染色减弱。结论:大鼠额叶皮质神经细胞bax mRNA和bcl-2 mRNA的表达水平受到慢性应激的影响,导致细胞凋亡加剧,西酞普兰能够有效调控额叶皮质神经细胞bax和bcl-2 mRNA的表达水平,拮抗细胞凋亡,这可能是西酞普兰防治慢性应激引起的神经精神疾病的相关机制之一。     

丁苯酞对酒精依赖大鼠海马谷氨酸含量及NR2B表达的影响

目的:研究丁苯酞(NBP)对酒精依赖大鼠海马谷氨酸(Glu)含量和NNMDA受体2B亚基(NR2B)表达的影响。方法:建立酒精成瘾大鼠模型,观察戒断症状,SYBR Green I荧光实时定量PCR技术检测海马区NR2BmRNA表达,高效液相色谱法检测海马组织中谷氨酸含量。结果:模型组大鼠戒断评分比正常组明显上升(P<0.01),NBP中、高剂量组与模型组相比,戒断评分明显下降(P<0.05),差异均有显著性;模型组大鼠海马区谷氨酸含量较正常组显著降低(P<0.01),差异有显著性,而各用药组与模型组相比,海马区谷氨酸含量差异无显著性(P>0.05);实时定量PCR结果表明模型组大鼠海马区NR2BmRNA表达较正常组明显增加(P<0.05),而NBP中、高剂量组与模型组相比,海马区NR2BmRNA表达明显减少,差异有显著性(P<0.05)。结论:NBP能够减轻酒精依赖大鼠的戒断症状,可能与NBP抑制NR2BmRNA表达有关。     

Nω-硝基-L-精氨酸甲酯抑制吗啡镇痛耐受大鼠中脑和脊髓一氧化氮合酶/N-甲基-D-天冬氨酸受体表达上调

采用热甩尾测痛法观察全身应用非特异性一氧化氮合酶（nitric oxide synthase,NOS）抑制剂——N^ω-硝基-L-精氨酸甲酯（L-NAME）对吗啡镇痛耐受形成的影响,并通过观察脊髓和中脑神经元型NOS（nNOS）和N-甲基-D-天冬氨酸（NMDA）受体亚单位表达的变化来阐释NO／NMDA受体在吗啡镇痛耐受形成中的作用。将36只健康成年Sprague-Dawley大鼠平均分为6组（每组6只）：1组为对照组,皮下注射生理盐水1ml;2、3、4、5和6组为处理组,分别皮下注射L-NAME10mg／kg、L-NAME20mg／kg、吗啡10mg／kg、L-NAME10mg／kg＋吗啡10mg／kg、L-NAME20mg／kg＋吗啡10mg／kg,每天2次。在注射前测量大鼠的热甩尾潜伏期（tail-flick latency,TFL）基础值,随后每天第一次给药50min后测量其TFL。第8天最后一次给药80min后（除2组和5组之外）断头取脊髓和中脑,采用RT-PCR技术测量nNOS以及NMDA受体1A（NR1A）和2A（NR2A）亚单位的表达。结果显示,2组大鼠第1天至第7天的TFL与基础值相比无显著差异;3组第7天时的TFL仍显著高于基础值;4组的TFL在第1天时最高,第2至第6天期间逐渐降低,第6天时与基础值相比无显著差异：5组的TFL在实验过程中呈下降趋势,虽然第7天时较第1天有所降低,但是仍然显著高于基础值;6组的TFL变化趋势与5组相同。PT—PCR分析结果显示,与1组相比,3组脊髓和中脑的nNOS mRNA表达显著降低,但NR1A mRNA和NR2A mRNA表达无显著改变;4组的nNOS mRNA、NR1A mRNA和NR2A mRNA表达均显著高于1组。与4组相比,6组的nNOS mRNA、NR1A mRNA和NR2A mRNA表达均显著降低。结果提示,吗啡镇痛耐受大鼠脊髓和中脑的nNOS和NMDA受体表达增加,联合应用L—NAME可抑制长期应用吗啡所致的nNOS表达增加和NMDA受体上调,延缓吗啡镇痛耐受的形成。本研究结果提示,脊髓和中脑的NO／NMDA受体与吗啡镇痛耐受形成密切相关。     

癫痫大鼠海马NMDA受体亚基NR2A和BDNFmRNA水平的检测

目的通过锂一匹罗卡品癫痫模型（ithium—pilocarpine seizures rats model of epilepsy,LPS）,研究NMDA受体亚基NR2A、BDNF mRNA的表达,探讨NR2A、BDNF在LPS中的作用。方法建立氯化锂-匹罗卡品大鼠模型,运用原位杂交技术检测致痫后各组不同时间点海马CAI、CA3及DG区NR2A与BDNF mRNA的表达。结果LPS海马NR2A、BDNF mRNA在各观察时间点及部位模型组与正常对照组比较均有明显上调,且有显著统计学差异（P〈0．05）。模型组NR2A mRNA的表达上调7d达峰值（P〈0．05）;而BDNF mRNA表达上调14d达峰值。VPA干预组NR2A mRNA在大鼠海马不同时间及部位（除1d的CA3区）的表达较模型组明显下调（P〈0．05）;BDNF mRNA在大鼠海马不同时间及部位（除28d的DG区）的表达较模型组明显下调（P〈0．05）。结论锂－匹罗卡品腹腔注射可诱导大鼠海马NR2A和BDNF mRNA的表达明显上调;NR2A mRNA表达的增强可能是诱导调控BDNF mRNA表达增强的重要机制之一,说明NMDA受体亚基NR2A可能成为抑制癫痫发作的新靶点。     

Physical, occupational, respiratory, speech, equine and pet therapies for mitochondrial disease

Treatments for mitochondrial disease, while developing, remain limited. Therapies complementary to traditional medical and surgical approaches may benefit the patient with mitochondrial disease. The goals of the 'allied health professions' of physical, occupational, speech and respiratory therapies are to maintain and if possible, improve patients' existing strength, functioning and mobility. These therapists also play an important role in helping patients to compensate for disabilities and adapt to progressive symptoms. Novel forms of physical and occupational therapies, equine or "hippotherapy" and pet therapy, use the human to animal relationship to improve physical and emotional health. To enhance quality of life, an integrated team of experts, under the guidance and supervision of the physician, should be available to the patient with mitochondrial disease.     

Targeting gene-virotherapy of cancer and its prosperity

Gene and viral therapies for cancer have shown some therapeutic effects, but there has been a lack of real breakthrough. To achieve the goal of complete elimination of tumor xenograft in animal models, we have developed a new strategy called Targeting Gene-Virotherapy of Cancer, which aims to combine the advantages of both gene therapy and virotherapy. This new strategy has produced stronger anti-tumor effects than either gene or viral therapy alone. A tumorspecific replicative adenovirus vector, designated as ZD55, was constructed by deletion of the 55kDa E1B region of adenovirus. The resulting viral construct not only retains a similar function to ONYX-015 by specifically targeting p53 negative tumors, but also allows for the insertion of various therapeutic genes to form appropriate ZD55 derivatives due to the newly introduced cloning site, a task not feasible with the original ONYX-015 virus. We showed that the anti-tumor effect of one such derivative, ZD55-IL-24, is at least 100 times more potent than that of either ZD55 virotherapy or Ad-IL-24 gene therapy. Nevertheless, complete elimination of tumor mass by the use of ZD55-1L-24 was only observed in some but not all mice, indicating that one therapeutic gene was not sufficient to ＂cure＂ these mice. When genes with complementary or synergetic effects were separately cloned into the ZD55 vector and used in combination （designated as the Dual Gene Therapy strategy）, much better results were obtained; and it was possible to achieve complete elimination of all the xenograft tumor masses in all mice if two suitable genes were chosen. More comprehensive studies based on this new strategy will likely lead to a protocol for clinical trial. Finally, the concept of Double Controlled Targeting Virus-Dual Gene Therapy for cancer treatment, and the implication of the recent progress in cancer stem cells are also discussed.     

Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains

Background:  Using quadruple clarithromycin‐containing regimens for Helicobacter pylori eradication is controversial with high rates of macrolide resistance. Aim:  To evaluate antibiotic resistance rates and the efficacy of empirical and tailored nonbismuth quadruple (concomitant) therapy in a setting with cure rates <80% for triple and sequential therapies. Methods:  209 consecutive naive H. pylori‐positive patients without susceptibility testing were empirically treated with 10‐day concomitant therapy (proton pump inhibitors (PPI), amoxicillin 1 g, clarithromycin 500 mg, and metronidazole 500 mg; all drugs b.i.d.). Simultaneously, 89 patients with positive H. pylori culture were randomized to receive triple versus concomitant therapy for clarithromycin‐susceptible H. pylori, and sequential versus concomitant therapy for clarithromycin‐resistant strains. Eradication was confirmed with ¹³C‐urea breath test or histology 8 weeks after completion of treatment. Results:  Per‐protocol (PP) and intention‐to‐treat eradication rates after empirical concomitant therapy without susceptibility testing were 89% (95%CI:84–93%) and 87% (83–92%). Antibiotic resistance rates were: clarithromycin, 20%; metronidazole, 34%; and both clarithromycin and metronidazole, 10%. Regarding clarithromycin‐susceptible H. pylori, concomitant therapy was significantly better than triple therapy by per protocol [92% (82–100%) vs 74% (58–91%), p = 0.05] and by intention to treat [92% (82–100%) vs 70% (57–90%), p = 0.02]. As for antibiotic‐resistant strains, eradication rates for concomitant and sequential therapies were 100% (5/5) vs 75% (3/4), for clarithromycin‐resistant/metronidazole‐susceptible strains and 75% (3/4) vs 60% (3/5) for dual‐resistant strains. Conclusions:  Empirical 10‐day concomitant therapy achieves good eradication rates, close to 90%, in settings with multiresistant H. pylori strains. Tailored concomitant therapy is significantly superior to triple therapy for clarithromycin‐susceptible H. pylori and at least as effective as sequential therapy for resistant strains.     

骨髓基质细胞的特征及其在细胞和基因治疗中的应用

骨髓基质细胞是一类独特的间质干细胞,可分化为多种非造血系的组织。骨髓基质细胞具有贴壁生长的特性,因而易于在体外分离和扩增;另外骨髓基质细胞可在体内外表达多种治疗性的外湖目的基因。因此,骨髓基质细胞被认为是一种理想的治疗性细胞的基因治疗中的靶细胞。本文对骨髓基质细胞的研究进展及其在细胞和基因治疗中的应用作一综述。     

四联疗法与序贯疗法根除幽门螺杆菌疗效观察

目的：探讨四联疗法和序贯疗法根除幽门螺杆菌的疗效和安全性。方法：将150例14C尿素呼气试验阳性的慢性胃炎患者随机分为A、B、C3组各50例。A组（四联疗法）给予雷贝拉唑、枸橼酸铋钾、克拉霉素、阿莫西林治疗7d;B组（序贯疗法）前5d给予雷贝拉唑、阿莫西林,后5d给予雷贝拉唑、克拉霉素、甲硝唑治疗;C组（标准三联疗法）给予雷贝拉唑、克拉霉素、阿莫西林治疗治疗7d。疗程结束4周后行14C尿素呼气试验检测。结果：A组根除率为94％,B组根除率为90％,c组根除率68％。A组和B组优于c组（P〈0．01）;A组、B组无显著差异性（P〉0．05）。三组均无严重不良反应。结论：四联疗法与序贯疗法H．pylori根除率优干标缝三联疗法．四联疗法和庠骨疗法疗效无．明昂差异性．     

Comparative efficacy and acceptability of psychotherapies for depression in children and adolescents: A systematic review and network meta‐analysis

Previous meta-analyses of psychotherapies for child and adolescent depression were limited because of the small number of trials with direct comparisons between two treatments. A network meta-analysis, a novel approach that integrates direct and indirect evidence from randomized controlled studies, was undertaken to investigate the comparative efficacy and acceptability of psychotherapies for depression in children and adolescents. Systematic searches resulted in 52 studies (total N=3805) of nine psychotherapies and four control conditions. We assessed the efficacy at post-treatment and at follow-up, as well as the acceptability (all-cause discontinuation) of psychotherapies and control conditions. At post-treatment, only interpersonal therapy (IPT) and cognitive-behavioral therapy (CBT) were significantly more effective than most control conditions (standardized mean differences, SMDs ranged from −0.47 to −0.96). Also, IPT and CBT were more beneficial than play therapy. Only psychodynamic therapy and play therapy were not significantly superior to waitlist. At follow-up, IPT and CBT were significantly more effective than most control conditions (SMDs ranged from −0.26 to −1.05), although only IPT retained this superiority at both short-term and long-term follow-up. In addition, IPT and CBT were more beneficial than problem-solving therapy. Waitlist was significantly inferior to other control conditions. With regard to acceptability, IPT and problem-solving therapy had significantly fewer all-cause discontinuations than cognitive therapy and CBT (ORs ranged from 0.06 to 0.33). These data suggest that IPT and CBT should be considered as the best available psychotherapies for depression in children and adolescents. However, several alternative psychotherapies are understudied in this age group. Waitlist may inflate the effect of psychotherapies, so that psychological placebo or treatment-as-usual may be preferable as a control condition in psychotherapy trials.     

Biological control of microbial infections and cancer in humans: Historical use to future potential

Prior to the advent of antibiotics, live organisms were used directly in attempts to control microbial infections and cure cancers. Examples of such biological control included bacteriotherapy, bacteriophage therapy, malaria therapy, probiotics and the use of living maggots. In all cases, the organisms themselves, rather than products of their metabolism, were used as the potentially curative agents. The history of the use of biocontrol agents in the treatment of human infections and cancer is discussed here in relation to more recent examples of the use of this approach. Modern studies suggest that the use of biological control in the treatment of human infections may be worth re‐evaluating in the light of the increasing world‐wide occurrence of antibiotic‐resistant bacteria and the opportunities provided by recent developments in gene technology.     

Applied Ethics in Animal Research: Philosophy,Regulations, and Laboratory Applications Edited by John P. Gluck,Tony DiPasquale,and F. Barbara Orlans

ABSTRACT

The goal of this study was to test if dolphin-assisted therapy could be an effective therapeutic intervention for children with significant social and communication disabilities. Furthermore, it was crucial to determine the relative importance of the dolphin and the parent consultation factors implicit in the therapy. The method employed was a before-and-after comparison of three control groups and one experimental group. In the experimental group, all three aspects of the therapeutic intervention—interaction with dolphins, parent counseling and a curative, relaxed environment—were included. Control group 1 (outpatient therapy group) was limited to just interaction with dolphins. In control group 2 (farm animal group), the parents were counseled after the children interacted with farm animals (which replaced dolphins). Control group 3 received no treatment. The post-treatment parent questionnaire results revealed therapeutic success in the areas of both productive and receptive language, processing of non-verbal cues, social skills, and self-confidence. Observations of parent–child interaction indicated that after treatment in the experimental group, interactions of children could be interpreted more accurately, on a long-term basis. The discovered therapeutic effects occurred regardless of whether the children were in the water during therapy or not.